Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

MedWellAI (MWAI) Shares Outstanding (Diluted Average) (2016 - 2026)

MedWellAI has reported Shares Outstanding (Diluted Average) over the past 10 years, most recently at $6.3 million for Q4 2025.

  • Quarterly Shares Outstanding (Diluted Average) rose 20.73% to $6.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.3 million through Dec 2025, up 20.73% year-over-year, with the annual reading at $5.7 million for FY2025, 29.28% up from the prior year.
  • Shares Outstanding (Diluted Average) was $6.3 million for Q4 2025 at MedWellAI, up from $6.2 million in the prior quarter.
  • Over five years, Shares Outstanding (Diluted Average) peaked at $291.2 million in Q4 2021 and troughed at $1.6 million in Q1 2022.
  • The 5-year median for Shares Outstanding (Diluted Average) is $5.3 million (2024), against an average of $57.1 million.
  • Year-over-year, Shares Outstanding (Diluted Average) crashed 99.31% in 2022 and then surged 681.51% in 2024.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $291.2 million in 2021, then crashed by 99.31% to $2.0 million in 2022, then skyrocketed by 111.37% to $4.2 million in 2023, then grew by 22.98% to $5.2 million in 2024, then increased by 20.73% to $6.3 million in 2025.
  • Per Business Quant, the three most recent readings for MWAI's Shares Outstanding (Diluted Average) are $6.3 million (Q4 2025), $6.2 million (Q3 2025), and $5.7 million (Q2 2025).